Theravance Biopharma (TBPH) Misses Q4 EPS by 31c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/28/2026

1. ORCL
2. AVGO
3. CDNS
4. ANT
5. META
6. BA
7. SPY
8. INTC
9. JBLU
10. HOOD

Go back to Theravance Biopharma (TBPH) Misses Q4 EPS by 31c

Needham & Company Reiterates Buy on Theravance Biopharma (TBPH) Following Conference Call

February 28, 2017 7:07 AM EST

Needham & Company reiterated a Buy rating and $40.00 price target on Theravance Biopharma (NASDAQ: TBPH) following the company's 4Q conference call.

Analyst Alan Carr commented, "Theravance mgmt hosted a 4Q16 conference call late yesterday to provide a corporate update. We note several expected... More